Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arsenic Trioxide in Advanced Renal Cell Carcinoma
NCT00005069Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Jan 2000
- Primary completion
- Jul 2001
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of arsenic trioxide in renal cell carcinoma (RCC), sponsored by Memorial Sloan Kettering Cancer Center. Started Jan 2000; status: completed.
02
Drugs
arsenic trioxide
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00005069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005069.